Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive

Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive — Trials · CancerIndex

Clinical trials

Registered studies

14 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 6
Recruiting: 2
Ph III recruiting: 1
Growth YoY: —
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02311998	Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML	completed	Phase 1 / Phase 2	22	M.D. Anderson Cancer CenterOTHER	1	Jul 17, 2023	clinicaltrials
NCT01456676	Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy	completed	Phase 1	11	Novartis PharmaceuticalsINDUSTRY	5	Dec 9, 2020